The 2020 Aliaxis SA Consolidated Annual Report has been published.
Sorry, your browser does not support inline SVG.

In a show of solidarity amid this terrible COVID-19 situation in India, Aliaxis managed to secured some 300 oxygen concentrators that have since been shipped to India from Poland and China.

India is still struggling to contain the wave of COVID-19 that has been sweeping through the country since March. The surge has led to severe oxygen and bed shortages across the country, which have put healthcare systems on the verge of collapse. In a show of solidarity amid this terrible situation, Aliaxis managed to secured some 300 oxygen concentrators that have since been shipped to India from Poland and China.

These medical devices remove nitrogen from the air to concentrate oxygen, and are critical for patients suffering from severe forms of the disease. Since their arrival in Bangalore earlier in May, our Ashirvad colleagues have been coordinating with the government and NGOs to deliver oxygen concentrators to 1,000+ people in need and to help ease the pressure on India’s healthcare system.

“We have deployed these oxygen concentrators in phases for oxygenated beds at government hospitals and step-down hospitals, created ‘Oxybanks’ for patients in self-isolation at home and extended support to NGOs by leveraging our depot infrastructure,” says Deepak Mehrotra, Managing Director of Ashirvad. “Special thanks to Aliaxis Poland for helping us secure these scarce oxygen concentrators.”

The Ashirvad team has also developed a prototype for a new oxygen concentrator, which they did in just a few days. The prototype is going through the certification process and has already achieved very promising results. Our first few concentrators will be sent to hospitals at the end of this week for field trials, before commercial production can start in early June. Having the ability to manufacture a home-grown solution will put Ashirvad in a better position to provide wider support when it comes to providing oxygen.